Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Pulse dipolar EPR for determining nanomolar binding affinities

Katrin Ackermann , Joshua L. Wort and Bela E. Bode *
EaStCHEM School of Chemistry, Biomedical Sciences Research Complex and Centre of Magnetic resonance, University of St Andrews, North Haugh, St Andrews, KY16 9ST, Scotland, UK. E-mail: beb2@st-andrews.ac.uk

Received 26th April 2022 , Accepted 11th July 2022

First published on 11th July 2022


Abstract

Protein interaction studies often require very low concentrations and highly sensitive biophysical methods. Here, we demonstrate that pulse dipolar electron paramagnetic resonance spectroscopy allows measuring dissociation constants in the nanomolar range. This approach is appealing for concentration-limited biomolecular systems and medium-to-high-affinity binding studies, demonstrated here at 50 nanomolar protein concentration.


The study of biomacromolecular assemblies and protein–protein interactions in a physiologically relevant context often requires sub-micromolar concentrations of their constituents. Quantitative analyses in this concentration regime are a challenge for every magnetic resonance technique and require extraordinary sensitivity.

Pulse Dipolar electron paramagnetic resonance Spectroscopy (PDS) has gained reputation as a highly accurate biophysical method affording superb concentration sensitivity.1–3 PDS provides distance distributions derived from dipolar coupling frequencies between paramagnetic centres (Fig. 1A), usually introduced via site-directed spin-labelling with stable radicals such as nitroxides or trityls, or paramagnetic metal ions such as GdIII or CuII.2,4–13 Since PDS is exclusively sensitive to these paramagnetic centres, size or complexity of the biomolecular system are not a limiting factor, providing valuable long-range distance constraints from in-solution to in-cell environments.3,5,14–26


image file: d2cc02360a-f1.tif
Fig. 1 Predicted spatial distribution of the R1 label and CuII-NTA in the GB1 mutant I6R1/K28H/Q32H based on crystal structure PDB 4WH4. (A) Simulated PDS trace with the modulation depth Δ indicated (left) and corresponding simulated distance distribution (right; MMM version 2021.2).27,28 (B) Structure drawing for the R1 label (top) and CuII-NTA (bottom) coordinated to two histidine residues. (C) Visualisation of the modelled R1 rotamers (purple clouds show the position of the nitroxide group bearing the unpaired electron, with the cloud sized according to the probability of the population; rotamers are displayed using ball and stick representation) and the predicted spatial Cu2+ distribution between the two histidine residues (red shape visualises distribution of modelled Cu2+ positions).

Two of the most popular PDS methods are Pulsed ELectron–electron DOuble Resonance (PELDOR aka DEER for Double Electron–Electron Resonance)29–31 and Relaxation Induced Dipolar Modulation Enhancement (RIDME),32,33 with methodology and hardware being continuously developed.34–39 Furthermore, deep learning based neural network processing40,41 of PDS data is rapidly gaining interest as it overcomes potential confirmation bias by the user and it has been recommended as a standard processing approach.42

In recent years, the use of genetically encoded double-histidine (dHis) motifs to bind paramagnetic metal ions, in particular CuII, has been established for PDS.7,27,43–45 Here, orthogonal labelling, that is, the combination of two spectroscopically distinct spin labels (in this case methanethiosulfonate (MTSL)6,46 and CuII-nitrilotriacetic acid (CuII-NTA),43Fig. 1B) with the RIDME method, has enabled PDS measurements in the sub-μM concentration regime.47 Nanomolar sensitivity for PDS could so far be demonstrated at 45 nM protein (90 nM spin) concentration using a new trityl spin label and a single-frequency method (double quantum coherence, DQC),2,34 and at ∼100 nM protein (200 nM spin) concentration using the spin label MTSL and PELDOR method.1,3 However, for the determination of dissociation constants (KDs) the orthogonal labelling approach is highly beneficial, as this allows preservation of the amplitude of the detected signal which encodes the dipolar coupling and binding site occupation (via the modulation depth Δ, illustrated in Fig. 1A) when ‘titrating’ one binding partner. Here, CuII-NTA is added in increasing amounts to saturation. This technique for KD determination is a direct approach similar to isothermal titration calorimetry (ITC),48 in contrast to secondary readouts such as native gel shift.49

Crucially, KD determination requires concentrations of the interacting partners approximately in the same order of magnitude as the dissociation constant itself.47,49 Thus, the biophysical method used must be of sufficient sensitivity. While nanomolar PDS-based binding studies would be highly desirable to have as complementary technique to ITC, a proof-of-principle study is currently lacking.

Here, the practical concentration limit for PDS-based binding studies on orthogonally labelled protein is approached using the well-established spin labels MTSL6,46 and CuII-NTA43 grafted on to the Streptococcus sp. Group G protein G, B1 domain (GB1), which has been extensively studied by EPR.7,9,43–45,50 We demonstrate that CuII-nitroxide RIDME binding studies are feasible as low as 50 nM protein concentration, thereby pushing the limit by an order of magnitude compared to previous data.47 This makes this technique appealing for protein interaction studies in physiological context, especially for concentration-limited biomolecular systems and for determination of nanomolar binding affinities, typical for important biomolecular interactions such as host-pathogen interactions, formation of enzyme-substrate complexes, or affinities of monoclonal antibodies.51–53

Previously, CuII-nitroxide RIDME measurements at 500 nM GB1 concentration yielded both, distance distributions and a dissociation constant.47 However, recent benchmarking of sensitivity limits1 suggests a further order of magnitude reduction in concentration may be feasible which is explored here.

A set of RIDME distance measurements was performed on the GB1 construct I6R1/K28H/Q32H (Fig. 1C) at 100 nM protein concentration with varying CuII-NTA concentrations (100 nM to 8.1 μM). Data were processed and validated using Tikhonov regularisation in DeerAnalysis201554 as described previously1 (for details see ESI). Modulation depths continuously increased with CuII-NTA concentration, and all extracted distance distributions gave the predicted mean distance (Fig. 2A and B). The emerging alternative deep neural network processing (DEERNet41 with RIDME background model40 within DeerAnalysis2022) confirmed these results (see ESI for details).


image file: d2cc02360a-f2.tif
Fig. 2 RIDME data for the 100 nM (top) and 50 nM (bottom) GB1 I6R1/K28H/Q32H pseudo-titration series. (A and C) Stacked raw RIDME traces (black) with background function (grey); (B and D) corresponding distance distributions given as 95% confidence estimates (±2σ) with 50% noise added for error estimation during statistical analysis. Colour bars represent reliability ranges (green: shape reliable; yellow: mean and width reliable; orange: mean reliable: red: no quantification possible).

Results suggest that 100 nM protein concentration is not yet the practical concentration limit. Therefore, protein concentration was further reduced to 50 nM GB1. Keeping the averaging times similar to the 100 nM experiments (i.e., about 60 hours per sample, which is approaching the economical and stability limits for measurements of this type), traces were expectedly about two-fold noisier, resulting in higher uncertainties in the distance distributions (Fig. 2C and D). Retrieved modulation depths were following the expected trend, and a repeat experimental set at 50 nM GB1 yielded comparable modulation depths, demonstrating robust data reproducibility even at very low protein concentrations (see ESI for details). Notably, DEERNet analysis failed for six of the ten 50 nM samples, attributed to the comparably poor signal-to-noise ratios, which is in line with recommendations that data of this quality should no longer be used to analyse distance distributions.42

All three experimental sets were analysed with respect to binding affinities as described previously.44,47 Briefly, binding isotherms were generated considering experimental modulation depths as a function of CuII-NTA concentrations to obtain respective dissociation constants (Fig. 3; see ESI for details). Results are in good agreement between the different experimental sets, with KD values in the nanomolar concentration range (10−7 to 10−8, a global KD value was fitted to 7 × 10−8, see ESI), close to previous PDS results, and consistent with ITC experiments.47 Differences between the data points of the two 50 nM sets are within the 95% confidence range. This demonstrates the validity of the approach of using PDS for low-concentration protein interaction studies and the determination of nanomolar affinities.


image file: d2cc02360a-f3.tif
Fig. 3 Binding isotherms for (A) 100 nM GB1 I6R1/K28H/Q32H and (B) 50 nM GB1 I6R1/K28H/Q32H. Fitted dissociation constants and 68% (1 × σ) confidence bounds (CI) are indicated on each plot.

Taken together, results demonstrate that both, binding studies and analysis of distance distributions are feasible down to 100 nM protein concentration at short to intermediate distances, whereas at 50 nM protein concentration modulation depths can still be obtained but under the present conditions, confident retrieval and interpretation of distance distributions is no longer possible due to the reduced signal-to-noise ratio,42 in the CuII-nitroxide RIDME case.

PDS data were quantitatively assessed by comparing sensitivity values of the three experimental sets internally and with previous datasets (see ESI for extensive analysis and discussion on sensitivities and tabulated values; see ref. 55 for the supporting research data).1,47 Briefly, we define sensitivity as the ratio of the amplitude of the signal over experimental noise (or modulation-depth-to-noise ratio). As expected, the sensitivity of the 100 nM series is within error double the magnitude of the average sensitivity of the 50 nM series. Taking a recent quantification for the nitroxide–nitroxide PELDOR case1 into account, CuII-nitroxide RIDME yields a comparable sensitivity but proves more robust towards extra losses at low concentration attributed to the more complex optimisation of PELDOR experiments (see ESI for details).

In this study, we demonstrate that PDS is a suitable technique for low-concentration protein interaction studies and the determination of nanomolar binding affinities. Importantly, affinities can be directly derived from the modulation depth that encodes the fraction of complexes formed. Measurements are performed at much lower expense of materials than in standard ITC conditions48 (here, samples were measured at 100 or 50 nM protein concentration in a total volume of 65 μL). Furthermore, samples do not need to be immobilised as in surface plasmon resonance.56 In addition, spectroscopic orthogonality of spin labels provides a handle for tying affinities to certain spin pairs in more complex binding equilibria. This may be impossible to disentangle using other techniques that measure e.g., the aggregate heat of binding. Thus, PDS binding studies have significant potential to complement the ITC “gold standard”.

The ability to accurately determine binding affinities in the nanomolar range is relevant for e.g., the investigation of host-pathogen interactions such as collagen-binding bacterial surface proteins,51 or SARS-CoV2 antibody affinities for vaccine design.53 A recent survey of protein–protein complexes including antigen–antibody and enzyme-inhibitor interactions found the majority of complexes (90 out of 144) having KDs from 10−6 to 10−10,52 highlighting the significance of this range.

In conclusion, data presented here demonstrate that quantitative analysis of PDS modulation depths for extraction of dissociation constants is still feasible down to tens of nanomolar protein concentration in favourable cases. Importantly, this holds even when distance distributions are no longer reliably retrievable. This widens the scope of PDS applications to low-concentration, medium-to-high-affinity protein interaction studies yielding high sensitivity and accuracy. This has significant potential to impact investigations of biomolecular systems that are concentration-limited and therefore, currently out of reach using traditional biophysical methods.49

This research was funded, in whole or in part, by the Wellcome Trust (204821/Z/16/Z). A CC BY or equivalent license is applied to the Author Accepted Manuscript arising from this submission, in accordance with the grant's open access conditions. B. E. B. and K. A. acknowledge support by the Leverhulme Trust (RPG-2018-397). J. L. W. acknowledges support by the BBSRC DTP Eastbio. B. E. B. acknowledges equipment funding by BBSRC (BB/R013780/1 and BB/T017740/1). We thank the StAnD (St Andrews and Dundee) EPR group for long-standing support and in particular Dr El Mkami for assistance with PDS experiments.

Conflicts of interest

There are no conflicts to declare.

References

  1. K. Ackermann, J. L. Wort and B. E. Bode, J. Phys. Chem. B, 2021, 125, 5358–5364 CrossRef CAS PubMed.
  2. N. Fleck, C. Heubach, T. Hett, S. Spicher, S. Grimme and O. Schiemann, Chem. – Eur. J., 2021, 27, 5292–5297 CrossRef CAS PubMed.
  3. S. Kucher, C. Elsner, M. Safonova, S. Maffini and E. Bordignon, J. Phys. Chem. Lett., 2021, 12, 3679–3684 CrossRef CAS PubMed.
  4. K. Ackermann, A. Chapman and B. E. Bode, Molecules, 2021, 26, 7534 CrossRef CAS PubMed.
  5. M. Azarkh, A. Bieber, M. Qi, J. W. A. Fischer, M. Yulikov, A. Godt and M. Drescher, J. Phys. Chem. Lett., 2019, 10, 1477–1481 CrossRef CAS PubMed.
  6. L. J. Berliner, J. Grunwald, H. O. Hankovszky and K. Hideg, Anal. Biochem., 1982, 119, 450–455 CrossRef CAS.
  7. T. F. Cunningham, M. R. Putterman, A. Desai, W. S. Horne and S. Saxena, Angew. Chem., Int. Ed., 2015, 54, 6330–6334 CrossRef CAS PubMed.
  8. D. M. Engelhard, A. Meyer, A. Berndhauser, O. Schiemann and G. H. Clever, Chem. Commun., 2018, 54, 7455–7458 RSC.
  9. A. Giannoulis, Y. Yang, Y.-J. Gong, X. Tan, A. Feintuch, R. Carmieli, T. Bahrenberg, Y. Liu, X.-C. Su and D. Goldfarb, Phys. Chem. Chem. Phys., 2019, 21, 10217–10227 RSC.
  10. G. Jeschke, Annu. Rev. Phys. Chem., 2012, 63, 419–446 CrossRef CAS PubMed.
  11. S. Razzaghi, M. Qi, A. I. Nalepa, A. Godt, G. Jeschke, A. Savitsky and M. Yulikov, J. Phys. Chem. Lett., 2014, 5, 3970–3975 CrossRef CAS PubMed.
  12. G. W. Reginsson, N. C. Kunjir, S. T. Sigurdsson and O. Schiemann, Chem. – Eur. J., 2012, 18, 13580–13584 CrossRef CAS PubMed.
  13. A. Shah, A. Roux, M. Starck, J. A. Mosely, M. Stevens, D. G. Norman, R. I. Hunter, H. El Mkami, G. M. Smith, D. Parker and J. E. Lovett, Inorg. Chem., 2019, 58, 3015–3025 CrossRef CAS PubMed.
  14. D. Constantinescu-Aruxandei, B. Petrovic-Stojanovska, O. Schiemann, J. H. Naismith and M. F. White, Nucleic Acids Res., 2016, 44, 954–968 CrossRef CAS PubMed.
  15. O. Duss, E. Michel, M. Yulikov, M. Schubert, G. Jeschke and F. H. T. Allain, Nature, 2014, 509, 588–592 CrossRef CAS PubMed.
  16. G. Hagelueken, W. J. Ingledew, H. Huang, B. Petrovic-Stojanovska, C. Whitfield, H. ElMkami, O. Schiemann and J. H. Naismith, Angew. Chem., Int. Ed., 2009, 48, 2904–2906 CrossRef CAS PubMed.
  17. R. Igarashi, T. Sakai, H. Hara, T. Tenno, T. Tanaka, H. Tochio and M. Shirakawa, J. Am. Chem. Soc., 2010, 132, 8228–8229 CrossRef CAS PubMed.
  18. J. J. Jassoy, A. Berndhäuser, F. Duthie, S. P. Kühn, G. Hagelueken and O. Schiemann, Angew. Chem., Int. Ed., 2017, 56, 177–181 CrossRef CAS PubMed.
  19. B. Joseph, A. Sikora, E. Bordignon, G. Jeschke, D. S. Cafiso and T. F. Prisner, Angew. Chem., Int. Ed., 2015, 54, 6196–6199 CrossRef CAS PubMed.
  20. C. Kapsalis, B. Wang, H. El Mkami, S. J. Pitt, J. R. Schnell, T. K. Smith, J. D. Lippiat, B. E. Bode and C. Pliotas, Nat. Commun., 2019, 10, 4619 CrossRef PubMed.
  21. I. Krstić, R. Hänsel, O. Romainczyk, J. W. Engels, V. Dötsch and T. F. Prisner, Angew. Chem., Int. Ed., 2011, 50, 5070–5074 CrossRef PubMed.
  22. H. Sameach, S. Ghosh, L. Gevorkyan-Airapetov, S. Saxena and S. Ruthstein, Angew. Chem., Int. Ed., 2019, 58, 3053–3056 CrossRef CAS PubMed.
  23. T. Schmidt, M. A. Wälti, J. L. Baber, E. J. Hustedt and G. M. Clore, Angew. Chem., Int. Ed., 2016, 55, 15905–15909 CrossRef CAS PubMed.
  24. F.-X. Theillet, A. Binolfi, B. Bekei, A. Martorana, H. M. Rose, M. Stuiver, S. Verzini, D. Lorenz, M. van Rossum, D. Goldfarb and P. Selenko, Nature, 2016, 530, 45–50 CrossRef CAS PubMed.
  25. B. Verhalen, R. Dastvan, S. Thangapandian, Y. Peskova, H. A. Koteiche, R. K. Nakamoto, E. Tajkhorshid and H. S. McHaourab, Nature, 2017, 543, 738–741 CrossRef CAS PubMed.
  26. Z. Yang, Y. Liu, P. Borbat, J. L. Zweier, J. H. Freed and W. L. Hubbell, J. Am. Chem. Soc., 2012, 134, 9950–9952 CrossRef CAS PubMed.
  27. S. Ghosh, S. Saxena and G. Jeschke, Appl. Magn. Reson., 2018, 49, 1281–1298 CrossRef CAS.
  28. Y. Polyhach, E. Bordignon and G. Jeschke, Phys. Chem. Chem. Phys., 2011, 13, 2356–2366 RSC.
  29. R. E. Martin, M. Pannier, F. Diederich, V. Gramlich, M. Hubrich and H. W. Spiess, Angew. Chem., Int. Ed., 1998, 37, 2833–2837 CrossRef PubMed.
  30. A. D. Milov, K. M. Salikov and M. D. Shirov, Fiz. Tverd. Tela, 1981, 23, 975–982 CAS.
  31. M. Pannier, S. Veit, A. Godt, G. Jeschke and H. W. Spiess, J. Magn. Reson., 2000, 142, 331–340 CrossRef CAS PubMed.
  32. L. V. Kulik, S. A. Dzuba, I. A. Grigoryev and Y. D. Tsvetkov, Chem. Phys. Lett., 2001, 343, 315–324 CrossRef CAS.
  33. S. Milikisyants, F. Scarpelli, M. G. Finiguerra, M. Ubbink and M. Huber, J. Magn. Reson., 2009, 201, 48–56 CrossRef CAS PubMed.
  34. P. P. Borbat and J. H. Freed, Chem. Phys. Lett., 1999, 313, 145–154 CrossRef CAS.
  35. P. P. Borbat, E. R. Georgieva and J. H. Freed, J. Phys. Chem. Lett., 2013, 4, 170–175 CrossRef CAS PubMed.
  36. A. Doll, S. Pribitzer, R. Tschaggelar and G. Jeschke, J. Magn. Reson., 2013, 230, 27–39 CrossRef CAS PubMed.
  37. C. L. Motion, S. L. Cassidy, P. A. S. Cruickshank, R. I. Hunter, D. R. Bolton, H. El Mkami, S. Van Doorslaer, J. E. Lovett and G. M. Smith, J. Magn. Reson., 2017, 278, 122–133 CrossRef CAS PubMed.
  38. P. E. Spindler, S. J. Glaser, T. E. Skinner and T. F. Prisner, Angew. Chem., Int. Ed., 2013, 52, 3425–3429 CrossRef CAS PubMed.
  39. P. E. Spindler, I. Waclawska, B. Endeward, J. Plackmeyer, C. Ziegler and T. F. Prisner, J. Phys. Chem. Lett., 2015, 6, 4331–4335 CrossRef CAS PubMed.
  40. J. Keeley, T. Choudhury, L. Galazzo, E. Bordignon, A. Feintuch, D. Goldfarb, H. Russell, M. J. Taylor, J. E. Lovett, A. Eggeling, L. Fábregas Ibáñez, K. Keller, M. Yulikov, G. Jeschke and I. Kuprov, J. Magn. Reson., 2022, 338, 107186 CrossRef CAS PubMed.
  41. S. G. Worswick, J. A. Spencer, G. Jeschke and I. Kuprov, Sci. Adv., 2018, 4, eaat5218 CrossRef CAS PubMed.
  42. O. Schiemann, C. A. Heubach, D. Abdullin, K. Ackermann, M. Azarkh, E. G. Bagryanskaya, M. Drescher, B. Endeward, J. H. Freed, L. Galazzo, D. Goldfarb, T. Hett, L. Esteban Hofer, L. Fábregas Ibáñez, E. J. Hustedt, S. Kucher, I. Kuprov, J. E. Lovett, A. Meyer, S. Ruthstein, S. Saxena, S. Stoll, C. R. Timmel, M. Di Valentin, H. S. McHaourab, T. F. Prisner, B. E. Bode, E. Bordignon, M. Bennati and G. Jeschke, J. Am. Chem. Soc., 2021, 143, 17875–17890 CrossRef CAS PubMed.
  43. S. Ghosh, M. J. Lawless, G. S. Rule and S. Saxena, J. Magn. Reson., 2018, 286, 163–171 CrossRef CAS PubMed.
  44. J. L. Wort, K. Ackermann, D. G. Norman and B. E. Bode, Phys. Chem. Chem. Phys., 2021, 23, 3810–3819 RSC.
  45. J. L. Wort, S. Arya, K. Ackermann, A. J. Stewart and B. E. Bode, J. Phys. Chem. Lett., 2021, 12, 2815–2819 CrossRef CAS PubMed.
  46. W. L. Hubbell and C. Altenbach, Curr. Opin. Struct. Biol., 1994, 4, 566–573 CrossRef CAS.
  47. J. L. Wort, K. Ackermann, A. Giannoulis, A. J. Stewart, D. G. Norman and B. E. Bode, Angew. Chem., Int. Ed., 2019, 58, 11681–11685 CrossRef CAS PubMed.
  48. M. M. Pierce, C. S. Raman and B. T. Nall, Methods, 1999, 19, 213–221 CrossRef CAS PubMed.
  49. I. Jarmoskaite, I. AlSadhan, P. P. Vaidyanathan and D. Herschlag, eLife, 2020, 9, e57264 CrossRef CAS PubMed.
  50. A. Gamble Jarvi, K. Ranguelova, S. Ghosh, R. T. Weber and S. Saxena, J. Phys. Chem. B, 2018, 122, 10669–10677 CrossRef CAS PubMed.
  51. S. Arora, J. Gordon and M. Hook, Front. Microbiol., 2021, 12, 628798 CrossRef PubMed.
  52. P. L. Kastritis, I. H. Moal, H. Hwang, Z. Weng, P. A. Bates, A. M. J. J. Bonvin and J. Janin, Protein Sci., 2011, 20, 482–491 CrossRef CAS PubMed.
  53. S. Shan, S. Luo, Z. Yang, J. Hong, Y. Su, F. Ding, L. Fu, C. Li, P. Chen, J. Ma, X. Shi, Q. Zhang, B. Berger, L. Zhang and J. Peng, Proc. Natl. Acad. Sci. U. S. A., 2022, 119, e2122954119 CrossRef CAS PubMed.
  54. G. Jeschke, V. Chechik, P. Ionita, A. Godt, H. Zimmermann, J. Banham, C. R. Timmel, D. Hilger and H. Jung, Appl. Magn. Reson., 2006, 30, 473–498 CrossRef CAS.
  55. K. Ackermann, J. L. Wort and B. E. Bode, Dataset, University of St Andrews Research Portal, 2022 DOI:10.17630/17631fece17639a17631-17667d17638-17642b17631-17638a17646-08944a17636ab17023.
  56. R. B. M. Schasfoort, in Handbook of Surface Plasmon Resonance (2), The Royal Society of Chemistry, 2017, pp. 1–26 10.1039/9781788010283-00001.

Footnotes

The research data supporting this publication can be accessed at https://doi.org/10.17630/1fece9a1-67d8-42b1-8a46-08944a6ab023.55
Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d2cc02360a

This journal is © The Royal Society of Chemistry 2022